Analytical Data
-
Gene name
CPVL
- Application
-
Alternative Names
Carboxypeptidase, vitellogenic-likeVitellogenic carboxypeptidase-like protein ;VCP-like protein ;hVLP
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H3G5
-
Expression Region
23-476aa
-
Molecular Weight
67.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on CPVL (Carboxypeptidase V-like protein) recombinant proteins has gained significant attention due to its potential implications in various biological processes and disease mechanisms. CPVL, a member of the carboxypeptidase family, is involved in protein digestion, maturation of peptide hormones, and the regulation of extracellular signaling pathways. Its expression has been linked to several pathological conditions, including cancer and inflammatory diseases. The ability to produce recombinant CPVL proteins allows for detailed studies of their structure, function, and interactions at a molecular level. This research facilitates the understanding of CPVL's role in physiology and pathology, enabling the development of targeted therapies. Moreover, the study of CPVL in recombinant form aids in characterizing its enzymatic mechanisms and optimizing its potential as a biomarker or therapeutic target. As such, the exploration of CPVL recombinant proteins is crucial for advancing both fundamental biological knowledge and clinical applications, laying groundwork for innovative strategies in disease management and treatment.
